Budget Amount *help |
¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2016: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
|
Outline of Final Research Achievements |
In our in vivo study, pharmacokinetics and histopathological findings of transarterial chemoembolization (TACE) using drug-eluting beads (DEB-TACE) were evaluated in a rabbit VX2 liver tumor model. As a result of our in vivo study, small size microspheres can contribute to the better distribution of microspheres and a higher drug concentration in non-hypervascular liver tumors such as VX2 tumor.
|